ATRIP and breast carcinoma: The current study adds to this emerging body of literature by reporting, for the first time in an Iranian family, a truncating ATRIP variant identified in multiple members with a strong history of breast cancer who had previously tested negative for pathogenic variants in established breast cancer genes assessed through multigene panel testing.